US6994979B2
Expired / Lapsed
US
⏱️ 0.0 years remaining
Conversion of apoptotic proteins
Assignee: Sanford Burnham Prebys Medical Discovery Institute
•
Filing: 2003-12-11
•
Granted: 2006-02-07
•
Expires: 2023-12-11
Abstract
Abstract Compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and Bcl-X L are identified. These compounds have the ability to convert the activity of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Methods for inducing apoptosis are described, together with methods for identifying molecules that induce apoptosis through interaction with Bcl-2-family members.
Inventors
- 👤 John C. Reed
- 👤 Xiao-kun Zhang
- 👤 Bin Guo
- 👤 Bingzhen Lin
- 👤 Siva Kumar Kolluri
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 09:41
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/5005; G01N33/5091; A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/1703; A61K38/1709; A61K38/177; A61P; A61P35/00; C; C07; C07K; C07K16/00; C07K16/18; C07K16/28; C07K16/2857; G01N33/5008; G01N33/5011; G01N33/502; G01N33/5076; G01N33/5079; G01N2510/00
Claims Analysis
Total Claims: 24
Claim 1
Independent Claim
61 words
A method of identifying molecules that induce apoptosis, comprising screening compounds using binding of said compounds to isotope-labeled Bcl-2 at the same site where TR3 binds, said site being different from the BH3-binding site on Bcl-2, said screening comprising: interacting isotope-labeled Bcl-2 with said compound in an appropriate buffer system to form a complex; and identifying where the compound is binding.
Claim 2
Independent Claim
61 words
A method of identifying molecules that induce apoptosis, comprising screening compounds using binding of said compounds to isotope-labeled Bcl-2 at the same site where TR3 binds, said site being different from the BH3-binding site on Bcl-2, said screening comprising: interacting isotope-labeled Bcl-2 with said compound in an appropriate buffer system to form a complex; and identifying where the compound is binding.
Claim 3
Dependent Claim
23 words
The method of claim 1 , wherein said isotope is selected from the group consisting of 15 N, 13 C, and 2 H.
Claim 4
Dependent Claim
20 words
The method of claim 1 , wherein nuclear magnetic resonance (NMR) is used to identify where the compound is binding.
Claim 5
Independent Claim
71 words
A method of identifying molecules that induce apoptosis, comprising: screening compounds to determine whether they bind to Bcl-XL labeled with an isotope at the same site where translationally controlled tumor protein (TCTP) binds, said site being different from the BH3-binding site on Bcl-XL, and assaying any of said compounds which bind to Bcl-XL labeled with an isotope at the same site where TCTP binds to determine whether the compound induces apoptosis.
Claim 6
Independent Claim
71 words
A method of identifying molecules that induce apoptosis, comprising: screening compounds to determine whether they bind to Bcl-XL labeled with an isotope at the same site where translationally controlled tumor protein (TCTP) binds, said site being different from the BH3-binding site on Bcl-XL, and assaying any of said compounds which bind to Bcl-XL labeled with an isotope at the same site where TCTP binds to determine whether the compound induces apoptosis.
Claim 7
Dependent Claim
16 words
The method of claim 4 , wherein said screening is carried out using high throughput screening.
Claim 8
Dependent Claim
23 words
The method of claim 4 , wherein said isotope is selected from the group consisting of 15 N, 13 C, and 2 H.
Claim 9
Dependent Claim
20 words
The method of claim 4 , wherein nuclear magnetic resonance (NMR) is used to identify where the compound is binding.
Claim 10
Independent Claim
102 words
A method for identifying molecules that induce apoptosis, comprising: (a) providing a labeled Bcl-2 binding compound bound to Bcl-2 forming a complex, wherein said Bcl-2 binding compound is known to induce a conformational change in Bcl-2 so as to be inductive of apoptosis; (b) contacting the Bcl-2 binding compound—Bcl-2 complex with a candidate agent, the candidate agent suspected of being able to induce a conformational change in Bcl-2 so as to be inductive of apoptosis, and (c) detecting dissociation of the labeled Bcl-2 binding compound from the complex, and (d) assaying the candidate agent to determine whether the candidate agent induces apoptosis.
Claim 11
Independent Claim
102 words
A method for identifying molecules that induce apoptosis, comprising: (a) providing a labeled Bcl-2 binding compound bound to Bcl-2 forming a complex, wherein said Bcl-2 binding compound is known to induce a conformational change in Bcl-2 so as to be inductive of apoptosis; (b) contacting the Bcl-2 binding compound—Bcl-2 complex with a candidate agent, the candidate agent suspected of being able to induce a conformational change in Bcl-2 so as to be inductive of apoptosis, and (c) detecting dissociation of the labeled Bcl-2 binding compound from the complex, and (d) assaying the candidate agent to determine whether the candidate agent induces apoptosis.
Claim 12
Dependent Claim
22 words
The method of claim 8 wherein NMR is used to identify a structure-activity relationship (SAR) between said Bcl-2 and said candidate agent.
Claim 13
Independent Claim
111 words
A method for identifying molecules that induce apoptosis, comprising: (a) detecting a labeled Bcl-X L binding compound bound to Bcl-X L , wherein said Bcl-X L binding compound is known to induce a conformational change in Bcl-X L so as to be inductive of apoptosis; (b) contacting the Bcl-X L binding compound—Bcl-X L complex with a candidate agent, the candidate agent suspected of being able to induce a conformational change in Bcl-X L so as to be inductive of apoptosis, and (c) detecting dissociation of the labeled Bcl-X L binding compound from the complex, and (d) assaying the candidate agent to determine whether the candidate agent an agent that induces apoptosis.
Claim 14
Independent Claim
111 words
A method for identifying molecules that induce apoptosis, comprising: (a) detecting a labeled Bcl-X L binding compound bound to Bcl-X L , wherein said Bcl-X L binding compound is known to induce a conformational change in Bcl-X L so as to be inductive of apoptosis; (b) contacting the Bcl-X L binding compound—Bcl-X L complex with a candidate agent, the candidate agent suspected of being able to induce a conformational change in Bcl-X L so as to be inductive of apoptosis, and (c) detecting dissociation of the labeled Bcl-X L binding compound from the complex, and (d) assaying the candidate agent to determine whether the candidate agent an agent that induces apoptosis.
Claim 15
Independent Claim
55 words
A method for identifying molecules that induce apoptosis, comprising: (a) contacting Bcl-X L with a candidate compound in the presence of a multidomain pro-apoptotic Bcl-2-family protein, and (b) detecting the association of Bcl-X L with such multidomain pro-apoptotic Bcl-2-family protein, whereby if association occurs, the candidate compound is identified as an agent that induces apoptosis.
Claim 16
Independent Claim
55 words
A method for identifying molecules that induce apoptosis, comprising: (a) contacting Bcl-X L with a candidate compound in the presence of a multidomain pro-apoptotic Bcl-2-family protein, and (b) detecting the association of Bcl-X L with such multidomain pro-apoptotic Bcl-2-family protein, whereby if association occurs, the candidate compound is identified as an agent that induces apoptosis.
Claim 17
Independent Claim
68 words
A method for identifying molecules that induce apoptosis, comprising: (a) contacting Bcl-2 with a candidate compound and a BH3 specific antibody under conditions where the BH3 domain of Bcl-2 is not accessible to a BH3 specific antibody, and (b) detecting the association of the BH3 specific antibody to the BH3 domain of Bcl-2, whereby if association occurs the candidate compound is identified as an agent that induces apoptosis.
Claim 18
Independent Claim
68 words
A method for identifying molecules that induce apoptosis, comprising: (a) contacting Bcl-2 with a candidate compound and a BH3 specific antibody under conditions where the BH3 domain of Bcl-2 is not accessible to a BH3 specific antibody, and (b) detecting the association of the BH3 specific antibody to the BH3 domain of Bcl-2, whereby if association occurs the candidate compound is identified as an agent that induces apoptosis.
Claim 19
Independent Claim
98 words
A method of identifying molecules that induce apoptosis, comprising: determining the ability of said molecule to bind to the loop region of a Bcl-2-familv protein and modulate the activity of said protein so as to be inductive of apoptosis, wherein said determining is by measuring the amount of labeled translationally controlled tumor-associated protein (TCTP) or TR3 bound to Bcl-2 family proteins anchored to a solid support in the presence and absence of molecules being tested, and determining the ability of each said molecules being tested to compete with TCTP or TR3 for binding sites on Bcl-2 family proteins.
Claim 20
Independent Claim
98 words
A method of identifying molecules that induce apoptosis, comprising: determining the ability of said molecule to bind to the loop region of a Bcl-2-familv protein and modulate the activity of said protein so as to be inductive of apoptosis, wherein said determining is by measuring the amount of labeled translationally controlled tumor-associated protein (TCTP) or TR3 bound to Bcl-2 family proteins anchored to a solid support in the presence and absence of molecules being tested, and determining the ability of each said molecules being tested to compete with TCTP or TR3 for binding sites on Bcl-2 family proteins.
Claim 21
Independent Claim
101 words
A method of identifying molecules that induce apoptosis, comprising: screening compounds using binding of said compounds to isotope-labeled Bcl-XL at the same site where translationally controlled tumor-associated protein (TCTP) binds, said site being different from the BH3-binding site on Bcl-XL, comprising: interacting isotope-labeled Bcl-XL with said compound in an appropriate buffer system; and performing nuclear magnetic resonance (NMR) on said complex to identify where the compound is binding, whereby when said candidate compound binds at the same site where TCTP binds, which is different from the BH3-binding site on Bcl-XL, the candidate compound is identified as an agent that induces apoptosis.
Claim 22
Independent Claim
101 words
A method of identifying molecules that induce apoptosis, comprising: screening compounds using binding of said compounds to isotope-labeled Bcl-XL at the same site where translationally controlled tumor-associated protein (TCTP) binds, said site being different from the BH3-binding site on Bcl-XL, comprising: interacting isotope-labeled Bcl-XL with said compound in an appropriate buffer system; and performing nuclear magnetic resonance (NMR) on said complex to identify where the compound is binding, whereby when said candidate compound binds at the same site where TCTP binds, which is different from the BH3-binding site on Bcl-XL, the candidate compound is identified as an agent that induces apoptosis.
Claim 23
Dependent Claim
23 words
The method of claim 14 , wherein said isotope is selected from the group consisting of 15 N, 13 C, and 2 H.
Claim 24
Dependent Claim
12 words
The method of claim 14 , wherein said isotope is 15 N.
References Cited (Backward Citations)
US6498195B2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2009-02-06 | 2009-08-08 | 2010-02-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2013-02-06 | 2013-08-08 | 2014-02-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2017-02-06 | 2017-08-08 | 2018-02-07 | $7700.00 | Window Closed / Lapsed |